Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of paliperidone efficacy.

Pharmacogenetics and genomics - 1 Jan 2017

Li Qingqin, Wineinger Nathan E, Fu Dong-Jing, Libiger Ondrej, Alphs Larry, Savitz Adam, Gopal Srihari, Cohen Nadine, Schork Nicholas J

Abstract excerpt

OBJECTIVE: Clinical response to the atypical antipsychotic paliperidone is known to vary among schizophrenic patients. We carried out a genome-wide association study to identify common genetic variants predictive of paliperidone efficacy. METHODS: We leveraged a collection of 1390 samples from individuals of European ancestry enrolled in 12 clinical studies investigating the efficacy of the extended-release...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genome-Wide Association Study
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Pharmacogenomic Variants

Share to Protein Kinases

Share to Psychiatric Status Rating Scales

Share to Schizophrenia

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 27846195
DOI: 10.1097/FPC.0000000000000250
PMCID: PMC5152628

Genes

ADCK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of paliperidone efficacy.PMID 27846195Read ↗

Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.Semantic proximity Read ↗

Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.Semantic proximity Read ↗

SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response.Semantic proximity Read ↗

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.Semantic proximity Read ↗

Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.Semantic proximity Read ↗

Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.Semantic proximity Read ↗

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsSemantic proximity Read ↗

Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disordersSemantic proximity Read ↗

Integrating Genome-wide and Epigenome-wide Associations for Antipsychotic Induced Extrapyramidal Side EffectsSemantic proximity Read ↗

Integrating genome-wide and epigenome-wide associations for antipsychotic induced extrapyramidal side effects.Semantic proximity Read ↗

Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.Semantic proximity Read ↗

Genomewide association study of movement-related adverse antipsychotic effects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.